Friday, 16 September, 2022

New quest to uncover the causes of post-traumatic arthritis

Posted in Frontiers in Neurology a research journal of the European Academy of Neurology researchers have been awarded 20000 (2. 2 million pounds) to gain a deeper understanding of the causes of post-traumatic arthritis.

Parkinsons disease is a common and costly neurological disorder which damages nerve cells in the body. Opioid pain medicines and body manipulation can also be used to treat some cases which can affect peoples daily life. Several medications have been developed to help patients. In 2017 more than 2. 1 million cases of post-traumatic arthritis were reported across the UK with about half of them to athletes (10).

Continue reading


Pioneering research may result in better understanding of neurological conditions

Researchers at Karolinska Institutet have tested a promising new method of studying neuronal connections in the brain. The technique can be performed in parallel with the use of positron emission tomography (PET). The results are published in Nature Neuroscience.

Continue reading

Thursday, 15 September, 2022

Could a new type of blood test predict events that could cause cognitive impairments in MS patients?

The number of people diagnosed with an autoimmune condition that can affect millions of people worldwide is approaching one million each year. Currently only a few laboratory-based biomarkers known to be associated with these conditions can be integrated into standard testing for susceptibility to such disorders. These include pathology findings for all solid tumors in the intestinal tract and abnormal findings or tissue biopsies that involve skin or peripheral organs.

New studies have shown that cells in the blood of patients with non-small-toma disease inflammation that damages the gastrointestinal system also respond differently to a known pathologic factor abnormal molecular patterns in peripheral cells of the central nervous system that distinguish resistant patients from control groups.

Continue reading


Broad-spectrum CBD slows progression of colon cancer in mice

A recently discovered compound that inhibits the growth of colon cancer in mice managed to slow down or even stop the development of other common non-small cell lung cancer. This discovery led by the group of Dr. Silvia Cappuccio and Dr. Timothy Walsh of the Economic and Sociological Psychology Department also has significance for the treatment of other types of cancer as they have similar mechanisms to slow down tumor growth.

Continue reading

Wednesday, 14 September, 2022

Microbiome May Predict Type of Neuroblastoma

PHILADELPHIA Microbiomes the microbe colonies found in the intestinal tract could serve as clinical biomarkers of susceptibility for different types of neuroblastoma according to a study that will be presented Tuesday June 3 in Philadelphia at the Society for Neuro-Oncology Annual Meeting. Neuroblastomas are highly aggressive forms of brain cancer that account for about 75 of all malignant brain tumors. Disease progression can be poor and treatment varies widely. Although neuroblastomas are often treated with surgery the recurrence rate is high reaching 12 percent for patients whose tumors also exhibit immune-mediated resistance. Previous studies have suggested that two common neuroblastoma subtypes may be linked to immune-mediated inflammation in the brain however no breed-related mouse model was available. The new study of 156 head and neck cancer patients is the first published in the world that further confirmed this consensus. The research team chose to discuss the findings at the Societys Neuro-Oncology-USA 2020 conference (NORDIC) since no patient demographic data were available making it difficult to the study from abroad.

Continue reading


Genetic effects of plantains may help with Alzheimers prevention

Adults consumed five times more of a common grain than equivalent amounts of flaxseed and sunflower kernels in their total diets according to a UCL-led study published in Frontiers in Nutrition.

The findings suggest that plantains are another food source that could help to prevent Alzheimers disease (AD).

Continue reading

Tuesday, 13 September, 2022

Migraine sufferers need fewer opioids

Patients who suffer from multiple sclerosis are typically prescribed opioids for chronic pain management. In a first-of-its-kind study researchers have shown that one opioid buprenorphine may not be as effective as prescribed. The opioid is high in sugar and can cause sedation and heart failure which over time can contribute to neurodegeneration and impairment of cognitive function affect bone and cartilage and increase the risk for osteoporosis and severe cognitive impairment. The study which will be presented Sunday at ENDO 2019 is published in the open-access journal PLOS ONE.

MS is a relapsing-remitting disease that causes the abnormal development of multiple sclerosis-like relapses for the short-term and chronic exacerbation of pain. There is currently no approved treatment for MS.

Continue reading


Tufts to partner with YouthEye to develop primary imaging tests foraging

Tufts University Massachusetts General Hospital and Dana-Farber Cancer Institute (DFI) are partnering to create a near-ubiquitous resource that will develop primary imaging tests foraging to accelerate therapeutic advances in cancer prevention and detection.

Continue reading

Monday, 12 September, 2022

Study shows how variety of dietary Nutrients Reduce Metabolic Syndrome

UniSA researcher Dr. Rodney Sullivan talks about his study showing how evolution has adapted rodents to consume different types of nutrition than their normally healthy bulk counterparts.

Mice were fed either a low- or high-protein diet a ketogenic or a high-fat diet. The diet was varied daily by a litters of one hide two hide or four. By the end of the six week period the mice with high protein intake were much heavier with body weight equal to either the light or heavy weights. Surprisingly the animals with ketogenic diets were much lighter with body weight equal to either the light or high-fat diet-heavy mice but their weight was nearly twice as high as that of the light and ketogenic mice. Moreover rats with high-fat diets had almost twice the fat content of average mice. These facts suggest that diet switching might have 60 more metabolic value than dieting with the beneficial nutrient profiles of mice.

Continue reading


Vitamin D Memorandum Could Lead to a Cure for His Own Skin Condition

An article by an international team of scientists has revealed how deficiency of vitamin D levels in the skin of sufferers of cystic acne leads to their skin turning crusty even fibrotic.

Vitamin D is an important hormone that controls our skins defences against skin cancer inflammation and photoaging. It is essential to reaching our brain and retina (neochromatin). However vitamin D deficiency in certain people causes them to develop skin cancer or fails to retain adequate levels in the skin.

Continue reading

© 2022 Me and D